EGFR and neoplasm: They function by entering the cells’ tyrosine kinase catalytic domain, blocking adenosine triphosphate binding, and inhibiting the EGFR signaling pathway, which in turn promotes tumor cell apoptosis; hampers tumor cell proliferation; and, ultimately, impedes tumor growth, thereby prolonging patient survival [7].